|
Main
|
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
16 December 2017 |
|
Main ID: |
NCT02023658 |
|
Date of registration:
|
09/12/2013 |
|
Prospective Registration:
|
Yes |
|
Primary sponsor: |
|
|
Public title:
|
Systems Analysis and Improvement to Optimize pMTCT
|
|
Scientific title:
|
Systems Analysis and Improvement to Optimize pMTCT: A Cluster Randomized Trial |
|
Date of first enrolment:
|
January 2014 |
|
Target sample size:
|
36 |
|
Recruitment status: |
Completed |
|
URL:
|
https://clinicaltrials.gov/show/NCT02023658 |
|
Study type:
|
Interventional |
|
Study design:
|
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Health Services Research. Masking: None (Open Label).
|
|
Phase:
|
N/A
|
|
|
Countries of recruitment
|
|
Côte D'Ivoire
|
Kenya
|
Mozambique
| | | | | |
|
Contacts
|
|
Name:
|
Kenneth Sherr, PhD |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
University of Washington |
| | |
|
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- health facility with pMTCT services in central Mozambique, northern Cote d'Ivoire or
western Kenya
- health facility with at least 20 HIV-infected women identified in antenatal care per
year
Exclusion Criteria:
- health facility over 20 kilometers from a main transport corridor
- health facility with an ongoing prospective study or systems analysis and improvement
approach in place
Age minimum:
N/A
Age maximum:
N/A
Gender:
Female
|
|
Health Condition(s) or Problem(s) studied
|
|
HIV
|
|
Intervention(s)
|
|
Other: pMTCT systems analysis and improvement
|
|
Primary Outcome(s)
|
|
Uptake of HIV counseling and testing at first antenatal care visit
[Time Frame: Patients will be assessed at first antenatal care visit (average of 25 weeks gestational age)]
|
|
Infant HIV determination
[Time Frame: 6 weeks post-partum]
|
|
Use of appropriate ARVs in pregnancy for prophylaxis or initiation of ART during pregnancy
[Time Frame: Patients will be assessed during the antenatal care period (average of 25-40 weeks gestational age)]
|
|
Uptake of CD4 testing at antenatal care
[Time Frame: Patients will be assessed during the antenatal care period (average of 25-40 weeks gestational age)]
|
|
Secondary ID(s)
|
|
44167-EG
|
|
R01HD075057
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|
Results
|
|
Results available:
|
|
|
Date Posted:
|
|
|
Date Completed:
|
|
|
URL:
|
|
|
|